Evidence map›Paper›PMID 41809196›Full record

ReviewFrontiers in neurology

Convolutional neural networks: applications, challenges and future prospects in brain tumor research.

Peng Zhang, Zhen Yang

Abstract readReview
In one paragraph

Review in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Peng ZhangDepartment of Neurosurgery, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, China.
Zhen YangDepartment of Neurosurgery, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As one of the most common malignant tumors in the central nervous system, brain tumors can cause neurological dysfunction and functional impairment. The early precise diagnosis, therapeutic efficacy evaluation, and prognosis prediction of brain tumors are of crucial significance for the formulation of treatment plans and the extension of survival periods for patients. In recent years, artificial intelligence (AI) has been applied in numerous biomedical fields, including the identification, diagnosis, and treatment of brain tumors. Deep learning (DL) is such an AI tool, and convolutional neural networks (CNNs) are widely used deep learning methods. With their powerful capabilities in automatic feature extraction and pattern recognition of images, CNNs have demonstrated great potential in the analysis of medical images of brain tumors. This paper systematically reviews the research progress of CNNs in brain tumors (tumor region identification and segmentation, benign and malignant classification, IDH mutation status prediction, and differentiation of pseudo-progression and recurrence), and deeply analyzes the current challenges and future development directions, aiming to provide a cutting-edge reference for neurosurgeons and researchers.

Indexed as

brain tumorconvolutional neural networkimage segmentationmagnetic resonanceprognosis prediction

Identifiers

PMID41809196
PMCPMC12967972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.